BIOPHARM FORWARD ApS: Financial statements 2018
CVR: 32438784
Source: annual report 2018, Danish Business Authority
26/08/2017 – 25/08/2018
BIOPHARM FORWARD ApS (CVR 32438784) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -1,877 and a net result of DKK -1,877 compared with DKK -1,727 the year before. Equity in the 2018 report amounted to DKK -30,102.
- Gross Profit
- DKK -1,877
- Profit/Loss
- DKK -1,877
- Equity
- DKK -30,102
- Total Assets
- DKK 693
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -2 t. | -2 t. | -30 t. | - |
| 2017 | - | -2 t. | -2 t. | -28 t. | - |
| 2016 | - | -1 t. | -1 t. | -26 t. | - |
| 2015 | - | -2 t. | -2 t. | -25 t. | - |
| 2014 | - | -2 t. | -2 t. | -24 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
BIOPHARM FORWARD ApS has published its annual report for 2017. Gross profit came to DKK -1,727, and the net result was DKK -1,727.
About BIOPHARM FORWARD ApS
BIOPHARM FORWARD ApS is a Danish company of the type Anpartsselskab based in Espergærde, founded in 2009. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jonas Hink. The company is owned by Jonas Hink. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK 997,234 and a net result of DKK 243,660 compared with DKK 385,061 the year before. Equity in the 2025 report amounted to DKK 1,741,315.